Adaptimmune Therapeutics Plc Precio/Ventas
¿Qué es el Precio/Ventas de Adaptimmune Therapeutics Plc?
El Precio/Ventas de Adaptimmune Therapeutics Plc es 1.60
¿Cuál es la definición de Precio/Ventas?
El ratio precio / ventas es el precio de las acciones de una empresa en comparación con sus ingresos.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Precio/Ventas de compañías en Sector Health Care en NASDAQ en comparadas con Adaptimmune Therapeutics Plc
¿Qué hace Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Empresas con precio/ventas similar a Adaptimmune Therapeutics Plc
- Mahindra EPC Irrigation tiene Precio/Ventas de 1.60
- Virtus Investment Partners Inc tiene Precio/Ventas de 1.60
- Aditya Birla Money tiene Precio/Ventas de 1.60
- Tinybeans tiene Precio/Ventas de 1.60
- TCI Finance tiene Precio/Ventas de 1.60
- Dish TV India tiene Precio/Ventas de 1.60
- Adaptimmune Therapeutics Plc tiene Precio/Ventas de 1.60
- Eumundi tiene Precio/Ventas de 1.60
- Tristel tiene Precio/Ventas de 1.60
- Royal Catering tiene Precio/Ventas de 1.60
- Zoom Telephonics tiene Precio/Ventas de 1.60
- Sabre Insurance Plc tiene Precio/Ventas de 1.60
- Matachewan Consolidated Mines tiene Precio/Ventas de 1.60